冠心病及冠心病合并糖尿病患者血清P-选择素与血脂、血糖相关性研究
|
摘要
目的:
观察冠心病及冠心病合并糖尿病患者血清P-选择素水平,分析其与血糖、血脂各项之间的关系,评价P-选择素、血糖,血脂各项在冠心病中血小板活化、及疾病病情判断,危险分层及预后估计中的意义。
方法:
以30例疑似病例者为对照组,102例入选患者,其中58例冠心病组(B组),冠心病组又分为不稳定型心绞痛组(B1组)28例和急性心梗组(B2组)30例;44例冠心病合并2型糖尿病组(C组),C组也分为不稳定型心绞痛组(C1组)24例和急性心梗组(C2组)20例,分别测定其血清P-选择素、空腹血糖、果糖胺、糖化血红蛋白、血脂等各项指标,并进行一般项目检查。P-选择素采用酶联免疫法测定;糖化血红蛋白采用胶体滤过法,血脂系列(包括TC、TG、LDL、HDL)及果糖胺、空腹血糖的检测采用常规生化法测定。
结果:
1)冠心病组及冠心病合并糖尿病组患者血清P-选择素水平均明显高于正常对照组(P＜0.05);
2)冠心病合并糖尿病组与单纯冠心病组相比,血清P-选择素水平明显升高(P＜0.05);
3)冠心病组、冠心病合并糖尿病组中,急性心梗与不稳定型心绞痛两组间相比较,急性心梗组血清P-选择素水平明显升高(P＜0.05);
4)病例组中血清P-选择素与低密度脂蛋白LDL呈正相关(R~2=0.498,0.572,0.468.0.517,P＜0.05);与TC呈正相关(R~2=0.403,0.512,0.423,0.508,P＜0.05);与HDL呈负相关(R~2=-0.408,-0.439,-0.501,-0,489,P＜0.05)C组与空腹血糖水平呈正相关(R~2=0.362,0.431,P＜0.05);与果糖胺水平呈正相关(R~2=0.264,0.401,P＜0.05);与糖化血红蛋白呈正相关(R~2=0.206,0.375,P＜0.05);
结论:
1)冠心病患者血清可溶性P-选择素水平显著高于正常人,其中AMI患者又较UA患者明显增高,说明UA及AMI患者存在血小板高活性状态,提示急性心梗较不稳定型心绞痛血小板活化更严重;它们的发生、发展与血小板功能亢进及血栓形成所致心肌缺血密切相关。
2)冠心病患者的总胆固醇、低密度脂蛋白胆固醇和P-选择素水平呈正相关,提示血脂可能有刺激血管炎症反应、激活血小板的作用。
3)冠心病合并糖尿病组血清P-选择素水平则较单纯冠心病组进一步升高,提示血糖升高在血小板活化,血清P-选择素水平增高的发展中可能起一定作用。
Objective:
To investigate changes in contents of human P-selectins and lipid(LDL,HDL,TQTC),and blood glucose(FBG,HBA1C,)in coronary heart disease(CHD),coronary heart disease with diabetic mellitus(DM).Analysis the relationship of P-selectins and lipid and blood glucose in CHD.Then evaluate the significances of P-selectins and lipid and blood glucose in platelet activation,destabilization of plaque,and predictor of future cardiovascular events.
Methods:
P-selectin,TC,TG,LDL,HDL,FBG,HbAlC,FTU,of l02 patients who were selected, were determined and compared to those of 30 patients healthy persons as control group.Among these patients,28 cases were unstable angina pectoris(group Bl),30 cases were acute myocardial infarction(group B2),24 cases were unstable angina pectoris complicating diabetic (group C1),20 cases were acute myocardial infarction complicating diabetic(group C2).The levels of P-selectin were measured by enzyme-linked immunosorbentassay(ELISA)technique and serum lipid(TC,TG,LDL,HDL,)and fasting blood glucose were measured by common practice examine.HBA1C were measured by latex agglutination immunoassay.
Results:
1)The level of P-selectins in CHD,CHD complicating with DM is obviously higher than in the normal control group(P＜0.05).The difference is statistically significant.
2)The level of P-selectins in CHD complicating with DM is obviously higher than in CHD group(P＜0.05).The difference is also statistically significant.
3)The level of P-selectins in AMI group is obviously higher than in the UAP group(P＜0.05).The difference is also statistically significant.
4)Pearson relation analysis showed that P-selectins level had significant positive correlation with LDL(R~2=0.498,0.572,0.468,0.517,P＜0.05),TC(R~2=0.403,0.512,0.423,0.508,P＜0.05),FBS(R~2=0.362,0.431,P＜0.05),FRU (R~2=0.264,0.401,P＜0.05),HBA1C(R~2=0.206,0.375,P＜0.05);and had appositive correlation with HDL(R~2=-0.408,-0.439,-0.501,-0.489,P,0.05)
Conclusion:
1)CHD patients have higher level of P-selectin which indicates that platelet activation is more serious in AMI patients than in UAP patients.
2)There are obvious positive correlation between the levels of P-selectin and lipids in patients with CHD.The total cholesterol and low density lipoprotein cholesterol may exacerbate the endothelial dysfunction,aggravate the systemic inflammation and activate the platelet in patients with CHD and CHD.complicating DM.
3)The serum P-selectin level in the CHD complicating DM is obviously higher than in the CHD.It shows that the blood glucose may exacerbate the endothelial dysfunction,aggravate the systemic inflammation and activate the platelet in patients with CHD complicating diabetic.
观察冠心病及冠心病合并糖尿病患者血清P-选择素水平,分析其与血糖、血脂各项之间的关系,评价P-选择素、血糖,血脂各项在冠心病中血小板活化、及疾病病情判断,危险分层及预后估计中的意义。
方法:
以30例疑似病例者为对照组,102例入选患者,其中58例冠心病组(B组),冠心病组又分为不稳定型心绞痛组(B1组)28例和急性心梗组(B2组)30例;44例冠心病合并2型糖尿病组(C组),C组也分为不稳定型心绞痛组(C1组)24例和急性心梗组(C2组)20例,分别测定其血清P-选择素、空腹血糖、果糖胺、糖化血红蛋白、血脂等各项指标,并进行一般项目检查。P-选择素采用酶联免疫法测定;糖化血红蛋白采用胶体滤过法,血脂系列(包括TC、TG、LDL、HDL)及果糖胺、空腹血糖的检测采用常规生化法测定。
结果:
1)冠心病组及冠心病合并糖尿病组患者血清P-选择素水平均明显高于正常对照组(P＜0.05);
2)冠心病合并糖尿病组与单纯冠心病组相比,血清P-选择素水平明显升高(P＜0.05);
3)冠心病组、冠心病合并糖尿病组中,急性心梗与不稳定型心绞痛两组间相比较,急性心梗组血清P-选择素水平明显升高(P＜0.05);
4)病例组中血清P-选择素与低密度脂蛋白LDL呈正相关(R~2=0.498,0.572,0.468.0.517,P＜0.05);与TC呈正相关(R~2=0.403,0.512,0.423,0.508,P＜0.05);与HDL呈负相关(R~2=-0.408,-0.439,-0.501,-0,489,P＜0.05)C组与空腹血糖水平呈正相关(R~2=0.362,0.431,P＜0.05);与果糖胺水平呈正相关(R~2=0.264,0.401,P＜0.05);与糖化血红蛋白呈正相关(R~2=0.206,0.375,P＜0.05);
结论:
1)冠心病患者血清可溶性P-选择素水平显著高于正常人,其中AMI患者又较UA患者明显增高,说明UA及AMI患者存在血小板高活性状态,提示急性心梗较不稳定型心绞痛血小板活化更严重;它们的发生、发展与血小板功能亢进及血栓形成所致心肌缺血密切相关。
2)冠心病患者的总胆固醇、低密度脂蛋白胆固醇和P-选择素水平呈正相关,提示血脂可能有刺激血管炎症反应、激活血小板的作用。
3)冠心病合并糖尿病组血清P-选择素水平则较单纯冠心病组进一步升高,提示血糖升高在血小板活化,血清P-选择素水平增高的发展中可能起一定作用。
Objective:
To investigate changes in contents of human P-selectins and lipid(LDL,HDL,TQTC),and blood glucose(FBG,HBA1C,)in coronary heart disease(CHD),coronary heart disease with diabetic mellitus(DM).Analysis the relationship of P-selectins and lipid and blood glucose in CHD.Then evaluate the significances of P-selectins and lipid and blood glucose in platelet activation,destabilization of plaque,and predictor of future cardiovascular events.
Methods:
P-selectin,TC,TG,LDL,HDL,FBG,HbAlC,FTU,of l02 patients who were selected, were determined and compared to those of 30 patients healthy persons as control group.Among these patients,28 cases were unstable angina pectoris(group Bl),30 cases were acute myocardial infarction(group B2),24 cases were unstable angina pectoris complicating diabetic (group C1),20 cases were acute myocardial infarction complicating diabetic(group C2).The levels of P-selectin were measured by enzyme-linked immunosorbentassay(ELISA)technique and serum lipid(TC,TG,LDL,HDL,)and fasting blood glucose were measured by common practice examine.HBA1C were measured by latex agglutination immunoassay.
Results:
1)The level of P-selectins in CHD,CHD complicating with DM is obviously higher than in the normal control group(P＜0.05).The difference is statistically significant.
2)The level of P-selectins in CHD complicating with DM is obviously higher than in CHD group(P＜0.05).The difference is also statistically significant.
3)The level of P-selectins in AMI group is obviously higher than in the UAP group(P＜0.05).The difference is also statistically significant.
4)Pearson relation analysis showed that P-selectins level had significant positive correlation with LDL(R~2=0.498,0.572,0.468,0.517,P＜0.05),TC(R~2=0.403,0.512,0.423,0.508,P＜0.05),FBS(R~2=0.362,0.431,P＜0.05),FRU (R~2=0.264,0.401,P＜0.05),HBA1C(R~2=0.206,0.375,P＜0.05);and had appositive correlation with HDL(R~2=-0.408,-0.439,-0.501,-0.489,P,0.05)
Conclusion:
1)CHD patients have higher level of P-selectin which indicates that platelet activation is more serious in AMI patients than in UAP patients.
2)There are obvious positive correlation between the levels of P-selectin and lipids in patients with CHD.The total cholesterol and low density lipoprotein cholesterol may exacerbate the endothelial dysfunction,aggravate the systemic inflammation and activate the platelet in patients with CHD and CHD.complicating DM.
3)The serum P-selectin level in the CHD complicating DM is obviously higher than in the CHD.It shows that the blood glucose may exacerbate the endothelial dysfunction,aggravate the systemic inflammation and activate the platelet in patients with CHD complicating diabetic.
引文
[1]杨永宗,主编.动脉粥样硬化性心血管病基础与临床.第一版.北京:科学出版社,2004,10.
[2]叶任高,内科学,第5版,北京人民卫生出版社,2002,798-825.
[3]Stollberger C,Finsterer J.Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis[J].Clin and Diagn Lab Immuno,200,9920;207-215
[4]Libby P,Ridker PM,Maseri A.Inflammation and atherosclerosis[J].Circulation,2002,105:1135-1143.
[5]Moore K L.Structure and function of P-selectin glycoprotein ligand 1[J].Leuk Lymphoma,1998,29(12):1 15.
[6]刘宁,吕晶.P-选择素与血小板活化.[J].国外医学·生理、病理科学与临床分册,2003,23(2):173-175.
[7]Blake GJ,Ridker PM.Novel clinical markers of vascular wallin flammation.Circ Res,2001,89:763-771.
[8]Aref S,Sakrana M,Hafez AA,et al.Soluble P-selectin levels in diabetes mellitus patient with Coronary artery disease.Hematology,2005,10(3):183-187
[9]Rohde LE,Hennekens CH,Redker PM.Cross-sectional study of soluble P-selectin and cardiovascular risk factors in apparently healthy men[J].Arterioscler Thromb Vesc Biol,1999,19:1595-1599.
[10]Altman R.Risk factors in coronary atherosclerosis athero-inflammation:the meeting point[J].Thromb J,2003,1(1):4-26.
[11]Gebuhrer V,Murphy JF,Bordet JC,etal.Oxidized low density lipoprotein induces the expression of P-seletin(GMP140/PADGEM/CD62)on human endothelial cells.[J].Biochem J,1995,15,306(Pt1):293-298.
[12]Yamazaki M,Uchiyama S,Iwate M.Measurement of platelet fibrinogenbind ingand P-selectin expression by flow cytometry in patients with cerebral infarction.Thromb Res,2001,104:197-205.
[13]Flather MD,Qeitz JI,Pogue J,et al.Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation:results of a randomized trial[J].Eur Heart J,2000,21:1473-1475.
[14]Shebuski RJ,Kilfore KS.Role of inflammatory mediators in thrombofenesis.Pharmacol Exp Ther.2002,300(3):729-735.
[15]Carter AM,Anagnostopoulou K,Mansfield MW,et al.Soluble P-selectin levels,P-selectin polymorphisms and cardiovascular disease.J Thromb Haemost,2003,1 (8):1718-1723.
[16]Kaikita K,Ogawa H,Yasue H,et al.Soluble P-selectin is released into the coeonary circulation after coronary spasm.Circulation.1995,92(7):1726-1730.
[17]Dong ZM,Broran AA,Wanger DD.Prominent role of P-selectin in the development of advance atherosclerosis in apoE-deficient mice.Circulation.2000,101(19):2290-2295.
[18]Phillips JW,Barringhaus KG,Sander JM,et al.Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient Mice.Circulation.2003,107(17):2244-2249.
[19]Qu XB,Sun ZQ,Chen MU,et al.The study of soluble P-selectin levels and it s correlation to the severity of coronary artery lesions in coronary heart disease.Zhong Hua Xin Xue Guan Bing Za Zhi.2005,26(8):617—21.
[20]Chou CA,Wu CJ,Yang CH,et al.Levels and value of soluble P-selectin following acute myocardial infarction:evaluating the link between soluble P-selectin levels and recruitment of circulating white blood cells and the marker for the rapid diagnosis of chest pain.Chang Gund Med.2005,28(10):699-707.
[21]Davies MJ.The pathophysiology of acute coronary syndromes.Heart.2000,83(3):361-366.
[22]Mcever RP.Selectin;Novel receptors that mediate leukocyte adhesion during inflammation.Thromb Haemost.1991,65(3):223-238.
[23]Mulvihill NT,Foley JB.Inflammation in acute coronary syndromes.Heart.2002,87(3):201-204.
[24]Davi G,Roman M,Mezzetti A et al.Increased levels of soiuble P-selectin in hypercholesterolemic patients.Circulation.1998,97(10):953-957.
[25]Chaudary AJ,Bhavalat RP,Kulkarni JN,et al.Interstitial curietherapy in penile carcinoma,preliminary study.Prog Urol,1991,1,(6):1028-1029.
[26]Wilson PW,DpAgostino RB,Levy D,et al.Prediction of coronary heart disease using risk factor categories.Circulation,1998,97(18):1837-1847.
[27]Wong ND,Wilson PW,Kannel WB,Serum cholesterol as a prognostic factor after myocardial infarction:the Framingham Study.Ann Intern Med,1991,115(9):687-693.
[28]Murohara T,Parkinson SJ,Waldman SA,et al.Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets.Role of protein kinase C.Arterioscler Thromb Vasc Biol,1995,15(11):2068-2075.
[29]Sudic D,Razmara M,Forslund M,et al.High glucose levels enhance platelet activation:involvement of multiple mechanisms.Br J Haematol,2006,133(3):315-322.
[30]崔建和,李红等.糖尿病患者血浆 P-选择素的表达及临床意义.[J].实用糖尿病杂志,2005,13(1):28-29.
[31]Merten M,Thigarajan P,P-selectin expression on platelet determines size and stability of p iatelet aggregates[J].Circulation,2000,102:1931-1936.
[32]Kalyanasundaram A,Elmore JR,Manazer JR,et al.Simvastatin suppresses experimental aortic aneurysm expansion.J Vase Surg.2006,43(1):117-24.
[33]Marschang P,Friedrich GL,Ditlbacher H,et al.Reducation of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease.Int J Cardiol,2006,106(2):183-90.
[34]Bruni F,Pasqui AL,Pastorelli M,et al.Different effect of statins on platelet oxidize-LDL receptor(CD36 and LOX-1)expression in hypercholesterolemic subjects.Clin Appl Thromb Hemost.2005,11(4):417-428.
[35]Bleske BE,Nicklas JM,Bard RL,et al.Neutral effect on markers of heart failure,inflammation,endothelial activation and function,and vagal tone after high-dose HMG-COA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.Am Coll Cardiol.2006,47(2):338-341.
[36]Mitsios JV,Papathanasiou AI,Ridis FI,et al.Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5weeks in patients with acute coronary syndromes syndromes.Circulation.2004,109(11):1335-8.
[37]Yamazaki M,Uchiyama S,Iwata M.Measurement of platelet fibrinongen binding and P-selectin expression by flow cytometry in patients with celebral infarction[J].Thromb Res,2001,104:197-205.
[38]Bienvenu J G,Tanguay J F,Theore J F,et al.Recombinant soluble P-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine[J].Circulation 2001,103:1128-1134.
[39]Laucella SA,Riarte A,Prado N,et al.Alpha 4 Integrins and siglyl Lewis x modulation in chronic Chagas disease:further evidence of persistent immune activation[J].Scand J Immunol 2001,53(5):514-519.
[40]Daniel Y,Geva E,Amit A,et al.Soluble endothelial and platelet selectins in serum and ascitic fluid of women with ovarian hyoerstimulation syndrome[J].Am J Reprod Immunol,2001,45(3):154-160.
[41]Daniel Y,Geva E,Amit A,et al.Do soluble cell adhesion molecules play a role in endometriosis[J].Am J Reprod Immunol,2000,43(3):160-166.
[42]Laucella SA,Segura EL,Riarte A,et al.Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1(sVCAM-1)decease during therapy with benznidazole in children with indeterminate form of Chagas' disease[J].Clin Exp Immunol,1999,118(3):423-427.
[43]Daniel Y,Kupfermine MJ,Baram A,et al.Plasma soluble endothelial selectin is patients with pre～eclampsia[J].Hum Reprod 1998,13(12):3537-3541.
[44]Alalar E,Aytemir K,Haznedaroglu I,et al.Increased plasma levels of soluble selectins in patients with unstable angina[J].Int J Cardiol,2001,78:69-73.
[1]叶任高主编.内科学(第五版)[M]北京人民卫生出版社,2001,80
[2]张静,张菲菲,沈玉翔等.心绞痛患者α颗粒膜蛋白及 D-二聚体的变化.中华内科杂志,1998,38:527-529.
[3]Becker RC,Tracy RP,Bovill EG,et al1 The clinical use of flow cytometry for assessing platelet activasion in acute coronary syndromes 1 TIM Ⅰ2ⅢThrombosis and Anticoagulation Groupl Coron Artery Dis,1994,5(4):339-345.
[4]DiVietro JA,Smith BR,et al.Immobilized IL-28 t rig2 gersprogressive activation of neut rophils rolling in vitro on P-selection and intercellular adhesion molecule21[J].J Immunol,2001,167(7):4017-4025.
[5]Evangelista Y,Manarini S,Sideri R et al.Platelet poly-morphonuclear leukocyte interaction:P-selectin trigger protein tyrosine phosphorylation-dependent CD11b/CD18 adhesion:Role of PSGL-1 as a signaling molecule.Blood 1999;93(3):876-885
[6]Frenette PS,Denis CV,Weiss L et al.P-selectin glycoprotein ligand 1(PSGL-1)is expressed on platelets and can mediate platelet-endothelial interactions in vivo.J Exp Med,2000;191:1413-1422
[7]Mcever RP.In:Beckerle MC.Cell Adhesion,Oxford:University Press,2001,30
[8]宋巍等.生命科学,2001,13:82
[9]Vandenderies ER et al.Thromb Haemost,2004,92:459
[10]Merten M et al.Circluation,2001 104:2955
[11]汤学明主编.医学细胞生物学,北京科学出版社,2004,226
[12]Keda H,Murohara T,Coronary thrombosis and cell adhesion molecules,Nippon Rinsho,1999,57(7):1502-1507
[13]赵水平主编.临床血脂学,北京人民卫生出版社,2006.328
[14]Mulvihill N,Foley JB.Inflammation in acute coronary syndromes Heart,2002,87(3):201-4
[15]刘文东.冠心病患者血清 P-选择素水平的变化,潍坊医学院学报,2005,27(6):435-436
[16]Murohara T,Parkinson SJ,Waldman SA,et al.Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets.Role of protein kinas[J].Arte-riosvler Thromb Vasc Biol,1995,15(11):2068-2075
[17]Murohara T,Scalia R,Lefer AM.Lysophophatidycholine promotes P-selectin expression in platelets and endothelial cells.Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors[J]. Circ Res,1996,78(5):780-9
[18]Kjew-Goodall Y,Wsdjam C,Stein BN,et al.State activation is essential for interleukin-4 induction of P-selectin transcription in human umbilical vein endothelial cells[J].Arterioscler Thromb Vasc Biol,1999,19(6):1421-9
[19]Davi J,Romano M,Mezzetti A,et al.Increased levels of soluble P-selectin in hypercholesterolemic patients.Circulation,1998,97(10):953-7
[20]Springer TA,Lasky LA,Cell adhesion.Sticky sugars for selectins.Nature,1991,349(6303),196-7
[21]Minamino T,Kitakaze M,Sanada S,et al.Increased expression of P-selectin on platelets is a risk factor for silent cerebral infraction in patients with atrial fibrillation:role of nitric oxide Circuulation,1998,98(17):1721-7
[22]Geng JG,Bevilacqua MP,Moore KL,et al.Rapid neutrophil adhesion to activated endothelium mediated by GMP140.Nature,1990,343(6260):757-60
[23]Stenberg PE,Mcever RP,Shuman MA,et al.A platelet alpha-granule membrane protein(GMP-140)is expressed on the plasma membrane after activation.[J]Cell Biol 1985.101(3):880-6
[24]Khew-Goodall Y,Wadham C,Stein BN,et al.State activation is essential for interleukin-4 induction of P-selectin transcripsion in human umbilical vein endothelial cells[J].Arterioscler Thromb Vasc Biol,1999,19(6):1421-9
[25]屈晓冰,孙振球,陈美娟,等冠心病患者 P-选择素水平及其与冠状动脉病变程度间的关系,中华临行病学杂志,2005,26(8):617-621
[26]周衍菊,张言镇,王洪光,等可溶性 P-选择素在不稳定型心绞痛危险分级中的意义,中国急救医学,2004,24(1:621
[27]应淑琴 P-选择素与心肌缺血再灌注损伤,心血管病学进展,2000,21(4):230-233
[28]Inhiwata S,Tukada T,Na kanishi S,et al.Postangiop lasty restenosis:Platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosislAmHeart J,1997,133(4):387-392
[29]Kralisz U,Mussur M,Jegier B,et al.Activation of blood plateiets after percutaneous transluminal coronary angiop lasty and coronary artery bypass graft surgery[J],Thrombbolysis,2000,1(3):255-264
[30]Aref S,S akrana M,Hale AA,et al.Souble P-selectin levels in diabetes mellitus patients with coronary artery disease.Hematology,2005,10(3): 183-187
[31]Tan KT,Tsyebjee MH,Lim HS,et al.Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.Diabet Med,2005,22(12):1657-1662
[32]Fuman MI,Benoit SE,Barnard UR,et al.Increased platelet reactivity and circulating monolyte-platelet aggregates in patients with stable coronary artery disease [J]Am Coll Cardial,1999,31:352-358
[2]叶任高,内科学,第5版,北京人民卫生出版社,2002,798-825.
[3]Stollberger C,Finsterer J.Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis[J].Clin and Diagn Lab Immuno,200,9920;207-215
[4]Libby P,Ridker PM,Maseri A.Inflammation and atherosclerosis[J].Circulation,2002,105:1135-1143.
[5]Moore K L.Structure and function of P-selectin glycoprotein ligand 1[J].Leuk Lymphoma,1998,29(12):1 15.
[6]刘宁,吕晶.P-选择素与血小板活化.[J].国外医学·生理、病理科学与临床分册,2003,23(2):173-175.
[7]Blake GJ,Ridker PM.Novel clinical markers of vascular wallin flammation.Circ Res,2001,89:763-771.
[8]Aref S,Sakrana M,Hafez AA,et al.Soluble P-selectin levels in diabetes mellitus patient with Coronary artery disease.Hematology,2005,10(3):183-187
[9]Rohde LE,Hennekens CH,Redker PM.Cross-sectional study of soluble P-selectin and cardiovascular risk factors in apparently healthy men[J].Arterioscler Thromb Vesc Biol,1999,19:1595-1599.
[10]Altman R.Risk factors in coronary atherosclerosis athero-inflammation:the meeting point[J].Thromb J,2003,1(1):4-26.
[11]Gebuhrer V,Murphy JF,Bordet JC,etal.Oxidized low density lipoprotein induces the expression of P-seletin(GMP140/PADGEM/CD62)on human endothelial cells.[J].Biochem J,1995,15,306(Pt1):293-298.
[12]Yamazaki M,Uchiyama S,Iwate M.Measurement of platelet fibrinogenbind ingand P-selectin expression by flow cytometry in patients with cerebral infarction.Thromb Res,2001,104:197-205.
[13]Flather MD,Qeitz JI,Pogue J,et al.Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation:results of a randomized trial[J].Eur Heart J,2000,21:1473-1475.
[14]Shebuski RJ,Kilfore KS.Role of inflammatory mediators in thrombofenesis.Pharmacol Exp Ther.2002,300(3):729-735.
[15]Carter AM,Anagnostopoulou K,Mansfield MW,et al.Soluble P-selectin levels,P-selectin polymorphisms and cardiovascular disease.J Thromb Haemost,2003,1 (8):1718-1723.
[16]Kaikita K,Ogawa H,Yasue H,et al.Soluble P-selectin is released into the coeonary circulation after coronary spasm.Circulation.1995,92(7):1726-1730.
[17]Dong ZM,Broran AA,Wanger DD.Prominent role of P-selectin in the development of advance atherosclerosis in apoE-deficient mice.Circulation.2000,101(19):2290-2295.
[18]Phillips JW,Barringhaus KG,Sander JM,et al.Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient Mice.Circulation.2003,107(17):2244-2249.
[19]Qu XB,Sun ZQ,Chen MU,et al.The study of soluble P-selectin levels and it s correlation to the severity of coronary artery lesions in coronary heart disease.Zhong Hua Xin Xue Guan Bing Za Zhi.2005,26(8):617—21.
[20]Chou CA,Wu CJ,Yang CH,et al.Levels and value of soluble P-selectin following acute myocardial infarction:evaluating the link between soluble P-selectin levels and recruitment of circulating white blood cells and the marker for the rapid diagnosis of chest pain.Chang Gund Med.2005,28(10):699-707.
[21]Davies MJ.The pathophysiology of acute coronary syndromes.Heart.2000,83(3):361-366.
[22]Mcever RP.Selectin;Novel receptors that mediate leukocyte adhesion during inflammation.Thromb Haemost.1991,65(3):223-238.
[23]Mulvihill NT,Foley JB.Inflammation in acute coronary syndromes.Heart.2002,87(3):201-204.
[24]Davi G,Roman M,Mezzetti A et al.Increased levels of soiuble P-selectin in hypercholesterolemic patients.Circulation.1998,97(10):953-957.
[25]Chaudary AJ,Bhavalat RP,Kulkarni JN,et al.Interstitial curietherapy in penile carcinoma,preliminary study.Prog Urol,1991,1,(6):1028-1029.
[26]Wilson PW,DpAgostino RB,Levy D,et al.Prediction of coronary heart disease using risk factor categories.Circulation,1998,97(18):1837-1847.
[27]Wong ND,Wilson PW,Kannel WB,Serum cholesterol as a prognostic factor after myocardial infarction:the Framingham Study.Ann Intern Med,1991,115(9):687-693.
[28]Murohara T,Parkinson SJ,Waldman SA,et al.Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets.Role of protein kinase C.Arterioscler Thromb Vasc Biol,1995,15(11):2068-2075.
[29]Sudic D,Razmara M,Forslund M,et al.High glucose levels enhance platelet activation:involvement of multiple mechanisms.Br J Haematol,2006,133(3):315-322.
[30]崔建和,李红等.糖尿病患者血浆 P-选择素的表达及临床意义.[J].实用糖尿病杂志,2005,13(1):28-29.
[31]Merten M,Thigarajan P,P-selectin expression on platelet determines size and stability of p iatelet aggregates[J].Circulation,2000,102:1931-1936.
[32]Kalyanasundaram A,Elmore JR,Manazer JR,et al.Simvastatin suppresses experimental aortic aneurysm expansion.J Vase Surg.2006,43(1):117-24.
[33]Marschang P,Friedrich GL,Ditlbacher H,et al.Reducation of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease.Int J Cardiol,2006,106(2):183-90.
[34]Bruni F,Pasqui AL,Pastorelli M,et al.Different effect of statins on platelet oxidize-LDL receptor(CD36 and LOX-1)expression in hypercholesterolemic subjects.Clin Appl Thromb Hemost.2005,11(4):417-428.
[35]Bleske BE,Nicklas JM,Bard RL,et al.Neutral effect on markers of heart failure,inflammation,endothelial activation and function,and vagal tone after high-dose HMG-COA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.Am Coll Cardiol.2006,47(2):338-341.
[36]Mitsios JV,Papathanasiou AI,Ridis FI,et al.Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5weeks in patients with acute coronary syndromes syndromes.Circulation.2004,109(11):1335-8.
[37]Yamazaki M,Uchiyama S,Iwata M.Measurement of platelet fibrinongen binding and P-selectin expression by flow cytometry in patients with celebral infarction[J].Thromb Res,2001,104:197-205.
[38]Bienvenu J G,Tanguay J F,Theore J F,et al.Recombinant soluble P-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine[J].Circulation 2001,103:1128-1134.
[39]Laucella SA,Riarte A,Prado N,et al.Alpha 4 Integrins and siglyl Lewis x modulation in chronic Chagas disease:further evidence of persistent immune activation[J].Scand J Immunol 2001,53(5):514-519.
[40]Daniel Y,Geva E,Amit A,et al.Soluble endothelial and platelet selectins in serum and ascitic fluid of women with ovarian hyoerstimulation syndrome[J].Am J Reprod Immunol,2001,45(3):154-160.
[41]Daniel Y,Geva E,Amit A,et al.Do soluble cell adhesion molecules play a role in endometriosis[J].Am J Reprod Immunol,2000,43(3):160-166.
[42]Laucella SA,Segura EL,Riarte A,et al.Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1(sVCAM-1)decease during therapy with benznidazole in children with indeterminate form of Chagas' disease[J].Clin Exp Immunol,1999,118(3):423-427.
[43]Daniel Y,Kupfermine MJ,Baram A,et al.Plasma soluble endothelial selectin is patients with pre～eclampsia[J].Hum Reprod 1998,13(12):3537-3541.
[44]Alalar E,Aytemir K,Haznedaroglu I,et al.Increased plasma levels of soluble selectins in patients with unstable angina[J].Int J Cardiol,2001,78:69-73.
[1]叶任高主编.内科学(第五版)[M]北京人民卫生出版社,2001,80
[2]张静,张菲菲,沈玉翔等.心绞痛患者α颗粒膜蛋白及 D-二聚体的变化.中华内科杂志,1998,38:527-529.
[3]Becker RC,Tracy RP,Bovill EG,et al1 The clinical use of flow cytometry for assessing platelet activasion in acute coronary syndromes 1 TIM Ⅰ2ⅢThrombosis and Anticoagulation Groupl Coron Artery Dis,1994,5(4):339-345.
[4]DiVietro JA,Smith BR,et al.Immobilized IL-28 t rig2 gersprogressive activation of neut rophils rolling in vitro on P-selection and intercellular adhesion molecule21[J].J Immunol,2001,167(7):4017-4025.
[5]Evangelista Y,Manarini S,Sideri R et al.Platelet poly-morphonuclear leukocyte interaction:P-selectin trigger protein tyrosine phosphorylation-dependent CD11b/CD18 adhesion:Role of PSGL-1 as a signaling molecule.Blood 1999;93(3):876-885
[6]Frenette PS,Denis CV,Weiss L et al.P-selectin glycoprotein ligand 1(PSGL-1)is expressed on platelets and can mediate platelet-endothelial interactions in vivo.J Exp Med,2000;191:1413-1422
[7]Mcever RP.In:Beckerle MC.Cell Adhesion,Oxford:University Press,2001,30
[8]宋巍等.生命科学,2001,13:82
[9]Vandenderies ER et al.Thromb Haemost,2004,92:459
[10]Merten M et al.Circluation,2001 104:2955
[11]汤学明主编.医学细胞生物学,北京科学出版社,2004,226
[12]Keda H,Murohara T,Coronary thrombosis and cell adhesion molecules,Nippon Rinsho,1999,57(7):1502-1507
[13]赵水平主编.临床血脂学,北京人民卫生出版社,2006.328
[14]Mulvihill N,Foley JB.Inflammation in acute coronary syndromes Heart,2002,87(3):201-4
[15]刘文东.冠心病患者血清 P-选择素水平的变化,潍坊医学院学报,2005,27(6):435-436
[16]Murohara T,Parkinson SJ,Waldman SA,et al.Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets.Role of protein kinas[J].Arte-riosvler Thromb Vasc Biol,1995,15(11):2068-2075
[17]Murohara T,Scalia R,Lefer AM.Lysophophatidycholine promotes P-selectin expression in platelets and endothelial cells.Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors[J]. Circ Res,1996,78(5):780-9
[18]Kjew-Goodall Y,Wsdjam C,Stein BN,et al.State activation is essential for interleukin-4 induction of P-selectin transcription in human umbilical vein endothelial cells[J].Arterioscler Thromb Vasc Biol,1999,19(6):1421-9
[19]Davi J,Romano M,Mezzetti A,et al.Increased levels of soluble P-selectin in hypercholesterolemic patients.Circulation,1998,97(10):953-7
[20]Springer TA,Lasky LA,Cell adhesion.Sticky sugars for selectins.Nature,1991,349(6303),196-7
[21]Minamino T,Kitakaze M,Sanada S,et al.Increased expression of P-selectin on platelets is a risk factor for silent cerebral infraction in patients with atrial fibrillation:role of nitric oxide Circuulation,1998,98(17):1721-7
[22]Geng JG,Bevilacqua MP,Moore KL,et al.Rapid neutrophil adhesion to activated endothelium mediated by GMP140.Nature,1990,343(6260):757-60
[23]Stenberg PE,Mcever RP,Shuman MA,et al.A platelet alpha-granule membrane protein(GMP-140)is expressed on the plasma membrane after activation.[J]Cell Biol 1985.101(3):880-6
[24]Khew-Goodall Y,Wadham C,Stein BN,et al.State activation is essential for interleukin-4 induction of P-selectin transcripsion in human umbilical vein endothelial cells[J].Arterioscler Thromb Vasc Biol,1999,19(6):1421-9
[25]屈晓冰,孙振球,陈美娟,等冠心病患者 P-选择素水平及其与冠状动脉病变程度间的关系,中华临行病学杂志,2005,26(8):617-621
[26]周衍菊,张言镇,王洪光,等可溶性 P-选择素在不稳定型心绞痛危险分级中的意义,中国急救医学,2004,24(1:621
[27]应淑琴 P-选择素与心肌缺血再灌注损伤,心血管病学进展,2000,21(4):230-233
[28]Inhiwata S,Tukada T,Na kanishi S,et al.Postangiop lasty restenosis:Platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosislAmHeart J,1997,133(4):387-392
[29]Kralisz U,Mussur M,Jegier B,et al.Activation of blood plateiets after percutaneous transluminal coronary angiop lasty and coronary artery bypass graft surgery[J],Thrombbolysis,2000,1(3):255-264
[30]Aref S,S akrana M,Hale AA,et al.Souble P-selectin levels in diabetes mellitus patients with coronary artery disease.Hematology,2005,10(3): 183-187
[31]Tan KT,Tsyebjee MH,Lim HS,et al.Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.Diabet Med,2005,22(12):1657-1662
[32]Fuman MI,Benoit SE,Barnard UR,et al.Increased platelet reactivity and circulating monolyte-platelet aggregates in patients with stable coronary artery disease [J]Am Coll Cardial,1999,31:352-358